Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.
Lee’s Pharmaceutical Holdings Limited announced a substantial financial performance improvement for the year ended December 31, 2024. The company reported a 32.9% increase in revenue and a 457.5% rise in profit attributable to owners compared to the previous year. This significant growth is reflected in the earnings per share, which also saw a dramatic increase. The Board has recommended a final dividend of HK2.5 cents per share, highlighting confidence in the company’s financial health and future prospects.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating primarily in the pharmaceutical industry. It focuses on developing, manufacturing, and marketing pharmaceutical products, with a significant emphasis on the Asian market.
Average Trading Volume: 285,012
Technical Sentiment Signal: Sell
Current Market Cap: HK$836.1M
For an in-depth examination of 0950 stock, go to TipRanks’ Stock Analysis page.